HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sara Colombetti Selected Research

Sara Colombetti Research Topics

Disease

16Neoplasms (Cancer)
03/2024 - 01/2006
2Hematologic Neoplasms (Hematological Malignancy)
12/2019 - 10/2018
2Melanoma (Melanoma, Malignant)
07/2012 - 01/2006
1Lymphoma (Lymphomas)
03/2024
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024
1Glioblastoma (Glioblastoma Multiforme)
10/2022
1Persistent Infection
10/2022
1Disease Progression
01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
11/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020

Drug/Important Bio-Agent (IBA)

5Bispecific AntibodiesIBA
01/2024 - 12/2019
5cibisatamabIBA
01/2021 - 01/2016
4AntigensIBA
10/2022 - 01/2006
4Carcinoembryonic AntigenIBA
01/2021 - 01/2016
3CytokinesIBA
10/2022 - 01/2021
2AntibodiesIBA
01/2020 - 10/2018
1glofitamabIBA
03/2024
1Azacitidine (5 Azacytidine)FDA Link
01/2024
1venetoclaxIBA
01/2024
1ErbB Receptors (EGF Receptor)IBA
10/2022
1epidermal growth factor receptor VIIIIBA
10/2022
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2022
1InterleukinsIBA
10/2022
1Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1N- propyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (PPTP)IBA
01/2021
1atezolizumabIBA
11/2020
1Blocking AntibodiesIBA
11/2020
1Granzymes (Granzyme)IBA
12/2019
1Proteins (Proteins, Gene)FDA Link
12/2019
1Neoplasm Antigens (Tumor Antigens)IBA
12/2019
1obinutuzumabIBA
10/2018
1Immunoglobulin G (IgG)IBA
01/2016

Therapy/Procedure

5Immunotherapy
01/2021 - 01/2006
3Therapeutics
01/2021 - 07/2012
1Investigational Therapies (Experimental Therapy)
01/2021
1Aftercare (After-Treatment)
09/2016